Projects per year
Personal profile
Research Area Keywords
- Cancer
Fingerprint
Dive into the research topics where Jun Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
Research output
- 8 Article
-
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy
Riveros, C., Ranganathan, S., Xu, J., Chang, C., Kaushik, D., Morgan, M., Miles, B. J., Muhammad, T., Anis, M., Aghazadeh, M., Zhang, J., Efstathiou, E., Klaassen, Z., Brooks, M. A., Rini, B., Wallis, C. J. D. & Satkunasivam, R., Mar 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 3, p. 150.e1-150.e9Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy
Riveros, C., Ranganathan, S., Xu, J., Chang, C., Kaushik, D., Morgan, M., Miles, B. J., Muhammad, T., Anis, M., Aghazadeh, M., Zhang, J., Efstathiou, E., Klaassen, Z., Brooks, M. A., Rini, B., Wallis, C. J. D. & Satkunasivam, R., Mar 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 3, p. 150.e1-150.e9Research output: Contribution to journal › Article › peer-review
-
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Burns, E. A., Gee, K., Kieser, R. B., Xu, J., Zhang, Y., Crenshaw, A., Muhsen, I. N., Mylavarapu, C., Esmail, A., Shah, S., Umoru, G., Sun, K., Guerrero, C., Gong, Z., Heyne, K., Singh, M., Zhang, J., Bernicker, E. H. & Abdelrahim, M., Jan 2023, In: Cancers. 15, 1, 81.Research output: Contribution to journal › Article › peer-review
Open Access -
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, K. T., Chevli, N. C., Messer, J. A., Haque, W., Farach, A. M., Satkunasivam, R., Zhang, J., Darcourt, J., Lo, S. S., Siva, S., Butler, E. B. & Teh, B. S., Mar 2023, In: Clinical and Translational Radiation Oncology. 39, 100592.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial
Satkunasivam, R., Lim, K., Teh, B. S., Guzman, J., Zhang, J., Farach, A., Chen, S. H., Wallis, C. J. D., Efstathiou, E., Esnaola, N. F. & Sonpavde, G. P., Aug 2022, In: Future Oncology. 18, 25, p. 2771-2781 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations